App and coach aim to cut diabetes risk in pregnancy
NCT ID NCT07189221
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This European study tests a program called B2B&ME+ that uses a smartphone app and personal health coaching to help pregnant women at high risk for gestational diabetes. 3600 women will be enrolled across four countries. The goal is to see if this approach can reduce diabetes and improve health for mothers and babies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Lifestyle intervention (smartphone app with Bluetooth scale and health coaching)
What this could lead to
If successful, this could provide a practical way to prevent gestational diabetes and improve long-term health for mothers and babies.
What could go wrong
This is an implementation study, not a drug trial. Results depend on how well women follow the program, and benefits may vary across countries and healthcare systems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS (GDM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••